|
Boston, Massachusetts USA, June 18, 2009.
Children’s
Hospital Boston and CompuCyte Corporation today announced the establishment of
an International Quantitative Imaging Cytometry Center of Excellence in Boston, to be jointly run by the two organizations. Under their agreement, Children’s
Hospital Boston and CompuCyte will create an educational resource focusing on
training programs and symposia for scientists using laser scanning cytometry in
cell- and tissue-based research. The Center represents an expansion of the
existing Centers of Excellence programs currently operating at Cold Spring
Harbor Laboratory in New York and the National University of Singapore.
Under the agreement, the Center will hold an annual
symposium devoted to advances in Quantitative Imaging Cytometry. The first
symposium is planned for August 2010 at Children’s Hospital Boston.
“The establishment of the QIC Center at Children’s Hospital
Boston is the outgrowth of productive collaborations between research teams in
the Longwood Medical Area and CompuCyte Corporation,” said Dr. Leslie
Silberstein, Director of the Joint Program in Transfusion Medicine and Center
for Human Cell Therapy at Children’s Hospital Boston. “We anticipate that the QIC Center, and the annual symposium in particular, will foster cross-disciplinary
collaborations employing quantitative image cytometry in a multiplicity of
cancer and stem cell research programs.”
“The creation of a worldwide network of QIC Centers has been
prompted by the rapidly expanding quantitative imaging cytometry network based
on CompuCyte’s laser scanning cytometry technology, and the growing number of
applications to which it is being applied, especially in the areas of cancer
and stem cell research,” said Dr. Elena Holden, CompuCyte’s President and CEO.
“The Boston area’s international reputation as an important hub of life science
research and education makes it a natural site for the Center’s operation, and
we are pleased to partner with Children’s Hospital Boston in this endeavor.”
An advisory committee consisting of recognized experts in
the field of cellular research will guide the Center:
-
Leslie Silberstein, M.D., Director of the Joint Program in
Transfusion Medicine, Children’s Hospital Boston and Professor of Pathology,
Harvard Medical School
-
Robert Hongbo Luo, Ph.D., Assistant Professor of Pathology, Joint
Program in Transfusion Medicine, Children’s Hospital Boston, Harvard Medical
School
-
Jerome Ritz, M.D., Medical Director, Connell and O’Reilly Cell
Manipulation Core Facility, Dana-Farber Cancer Institute, Professor of
Medicine, Harvard Medical School
-
Lynda Chin, M.D., Dana Farber Cancer Institute, Associate
Professor of Medicine, Harvard Medical School
-
James Jacobberger, Ph.D., Professor of Oncology, Case Western
Reserve University and Director, Cell Analysis Core, Case Comprehensive Cancer
Center, Cleveland OH
-
Elena Holden, M.D., President and CEO, CompuCyte Corporation
Children's Hospital Boston is home to the world's largest
research enterprise based at a pediatric medical center, where its discoveries
have benefited both children and adults since 1869. More than 500 scientists,
including eight members of the National Academy of Sciences, 11 members of the Institute of Medicine and 12 members of the Howard Hughes Medical Institute comprise
Children's research community. Founded as a 20-bed hospital for children,
Children's Hospital Boston today is a 397-bed comprehensive center for
pediatric and adolescent health care grounded in the values of excellence in
patient care and sensitivity to the complex needs and diversity of children and
families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. The hospital has a long and collaborative history with most of the
local academic and health care institutions and private industry partners in
promoting basic and translational research. Its partnerships reach beyond
Boston, throughout New England to many other U.S. academic and health care
institutions and pharmaceutical companies. It currently has research
agreements with more than 235 industry partners. For more information about the
hospital and its research, visit
www.childrenshospital.org
CompuCyte Corporation, a private company headquartered in Westwood, Massachusetts, is a leader in the development of cellular analysis
instrumentation for life science research, drug safety, toxicology studies and
clinical trials. The company’s iCyte®, iCys®, and iColor®
cytometers enable quantitative cytometric image analysis of cellular and
tissue specimens. More information about the technology may be found at www.compucyte.com.
Contact:
|
